Testing safety and efficacy of phage therapy for the treatment of antibiotic-resistant bacterial infections
Pays a fixed EUR 15 million grant to run multicentre clinical trials proving bacteriophage therapy works against antibiotic-resistant infections.
About
Proposals must include a sound clinical trial protocol, a delivery date for regulatory approval within 12 months of project start, and a clear exploitation pathway toward marketing authorisation. Start-ups and SMEs are specifically encouraged to participate to strengthen their scientific and commercial potential, and applicants are encouraged to use AI or computational modelling to optimise trial …
BiotechMedtech
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.